HIM
CNCE

Hillsdale Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Hillsdale Investment Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,400
Closed -$143K – 540
2017
Q1 		$143K Buy
+8,400
New +$143K 0.03% 292